There is growing evidence that E2 activates MEK/ERK pathways in ERα-positive cells, for example, E2 stimulates ERK1/2 pathway in thyroid cancer cell lines (KAT5 and WRO) through ER (21). The gene discussed is ESR1; the disease is thyroid gland carcinoma.